Press Releases

No Image

Transformational News and Alternatives to Flower Entice New Cannabis Consumers Alike

NEW YORK, June 6, 2019 /PRNewswire/ — As the Canadian cannabis market continues to mature, the consumer market is expected to witness a proliferation of edibles and other alternative cannabis-based products. Alternative products have become increasingly popular over recent years as consumers continue to stray away from traditional flower. Now shoppers are opting towards products such as concentrates and extracts, which are considered much more potent and cleaner when compared to smoking flower. Emerging products are expected to deliver annual revenue of more than CAD 2.5 Billion and generate higher profits for retailers than cannabis products that are already legal, according to Deloitte’s annual cannabis industry report. In addition to new products, Deloitte mentions other growth drivers such as the introduction of the alcohol and tobacco industry, mergers and acquisitions, and the entry of pharmaceutical companies. However, Deloitte is also forecasting that edibles are expected to be the primary growth driver for the overall Canadian market, as edible and alternative cannabis-based products are expected to account for CAD 1.6 Billion of the total CAD 2.5 Billion marketplace. Infused beverages (CAD 529 Million), topicals (CAD 174 Million), concentrates (CAD 140 Million, tinctures (CAD 116 Million), and capsules (114 Million) also make it on the list. In combination, the global market for alternative products is expected to double over the next five years, reaching USD 194 Billion. And while the U.S. marketplace accounts for a majority of the global market share, Deloitte highlights that Canada is better positioned than the U.S. The firm notes that Canadian-based cannabis companies receive significant advantages over its global counterparts, such as government support, access to capital markets and the banking system, as well as a unified market. As a result, the U.S. is expected to see its market share dwindle as more global players enter into the cannabis industry. Nonetheless, the U.S. market is still expected to thrive, especially after the passage of the U.S. Farm Bill last year. Pasha Brands Ltd. (CSE: CRFT, Walgreens Boots Alliance, Inc. (NASDAQ: WBA), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY)


No Image

CBD Beauty is Blossoming, say Analysts at Jefferies

PALM BEACH, Florida, June 6, 2019 /PRNewswire/ — According to a recent industry article published this year, Jefferies analysts, after initiating coverage on the cannabis markets, followed up with additional coverage specific to the CBD industry and in particular CBD beauty products. The article suggests Jefferies believes the CBD beauty market could reach $25 Billion globally in the next 10 years and could even amass 15 percent of the total skincare market. The incredible potential of the CBD beauty market is thought to be enormous, given the possibility that many products could be sold over the counter and without the need for a prescription, clearly allowing consumers access to the products easily. CBD beauty products have quickly become all the rage now that industry analysts estimate it could be an entirely separate category from both recreational and medical marijuana. That’s opening a wide range of opportunity for companies including The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF), Aleafia Health (TSX-V:ALEF) (OTC:ALEAF), Curaleaf Holdings Inc. (CSE:CURA) (OTC:CURLF), and Westleaf Inc. (TSX-V:WL) (OTC:WSLFF).




No Image

Purpl Scientific Unveils the World’s First Portable, Instant Cannabis Potency Testing Device

ST. LOUIS, June 6, 2019 /PRNewswire/ — Purpl Scientific announced today that, after several years in development and a successful beta test, the Company has launched its groundbreaking portable cannabis potency testing solution to the world. Named the Purpl PRO, the device brings unprecedented mobility, insight and limitless lab-accurate THC and CBD tests to a market with a glaring need for transparency and accountability. The Purpl PRO is available for sale through authorized distributors for $1,495.




No Image

Medicine Man Technologies Closes on First Phase of Initial $14 Million Strategic Investment from Dye Capital & Company

DENVER, June 6, 2019 /PRNewswire/ — Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, announced today that it has entered into a securities purchase agreement for the sale of up to $14 million of the Company’s common stock from an affiliate of Dye Capital & Company (“Dye Capital”).


No Image

Lucid Green launches ‘The Single Source Of The Truth For Cannabis Products’

NEW YORK, June 6, 2019 /PRNewswire/ — Lucid Green Inc., is the leading Cannabis trust and transparency platform that delivers vital product usage, safety and feedback information to consumers. Today Lucid Green launches the first Cannabis digital platform for products that centralizes a Brands product assets into one place, which can then be distributed “in real time” to all partners. Brands can now control the consistency of their product messaging and imagery. Lucid Green is making it easier for partners to spread the love, ensuring that all product details and descriptions across all channels contain the same unified messaging: from retailers for on-line menus and inventory control, to journalists and labs for product shots and descriptions.